Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2011
Home
2011
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Annual Report to Shareholders
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Pro Forma Appendix 3B
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Appendix 4C
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Non-Renounceable Rights Issue Despatch of Offer Document
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
US Patent for the Prevention or Treatment of Ischemia
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Results of Meeting
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Amended Constitution
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Rights Issue and Placement of Shortfall
November 14, 2019
Published by
Tiffany McMillan
on
November 14, 2019
Categories
Completed Midkine Study for Normal Reference Range
Prev page
1
2
3
4
5
Next page
